Amneal (AMRX) Director John Kiely Sells Shares

What Happened

• John Kiely, a director of Amneal Pharmaceuticals (AMRX), sold 50,000 shares in an open-market/private sale on 2026-08-13 for a weighted average price of $17.64, generating approximately $882,000 in proceeds. The filing also shows a gift of 10,000 shares (reported with $0 proceeds) to a donor-advised fund.

Key Details

• Transaction date: 2026-08-13.
• Sale: 50,000 shares at a weighted average price of $17.64 (range $17.26–$17.88 per share); proceeds ≈ $882,000. (Footnote F1: price is weighted average across multiple trades; reporting person can provide per-trade breakdown on request.)
• Gift: 10,000 shares donated to a donor-advised fund (Footnote F2: charitable donation).
• Shares owned after transaction: not specified in the details provided.
• Filing timeliness: Form 4 filed 2026-08-14 for 2026-08-13 transactions — appears timely (no late filing flag).

Context

• Sales by directors are often routine (liquidity, portfolio management) and do not by themselves signal company outlook; gifts to donor-advised funds are philanthropic and likewise do not indicate market sentiment. The filing’s footnotes clarify the sale prices were across multiple transactions and that the donation was to a donor-advised fund.